News | Interventional Radiology | January 08, 2018

Guerbet Announces Acquisition of Accurate Medical Therapeutics

Israel-based Accurate develops microcatheters for image-guided embolization procedures

Guerbet Announces Acquisition of Accurate Medical Therapeutics

January 8, 2018 —Guerbet announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical Therapeutics , which specializes in the development of microcatheters used in interventional radiology.

Accurate has developed a range of microcatheters for embolization procedures of tumors and vascular aneurysms. These products are currently being registered with the U.S. and European health authorities.

This range includes two series of microcatheters:

  • The first series was designed and developed to propose an optimization of microcatheters intra-arterial navigation to interventional radiologists, even in case of tortuous vascular network and hardly accessible lesions; and
  • The second series possess the same optimized navigation qualities, while also incorporating anti-reflux technology. This effect is achieved thanks to side holes located in the terminal part of the catheter, which create a fluid barrier preventing the reflux of embolization microspheres.

This new technology makes it possible to administer more embolization microspheres to the targeted treatment area while also preventing them from refluxing upstream to arteries irrigating healthy tissues (non-targeted areas that need to be preserved).

For more information: www.guerbet.com

Related Content

Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
Overlay Init